跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 99,207 条关于
“ER+/HER2+ breast cancer”
全部
99,207
临床试验
80,204
药物
2,710
机构
1,175
资讯
15,118
去年
Incyclix Bio's INX-315 Shows Promise in Advanced Breast and Ovarian Cancers
去年
Nivolumab Plus Chemotherapy Significantly Improves Cure Rate in Common Breast Cancer
去年
ADELA Phase III Trial Explores Elacestrant and Everolimus Combination for Advanced Breast Cancer
去年
Olema Oncology Secures $250M Funding and Novartis Partnership for Phase 3 Breast Cancer Trial
去年
Veru Initiates Phase 2 Trial of Enobosarm Plus Abemaciclib in AR+ ER+ HER2- Metastatic Breast Cancer
11年前
Abemaciclib Shows Promise in ER+/HER2- Advanced Breast Cancer Treatment
去年
Arvinas Advances Vepdegestrant into Phase 3 Trials for Breast Cancer and Updates Pipeline Milestones
去年
Olema Oncology and Pfizer Launch Phase 1b/2 Trial Combining Palazestrant with Atirmociclib for ER+/HER2- Metastatic Breast Cancer
9个月前
SAGA Diagnostics Presents Breakthrough MRD Data at SABCS 2025, Demonstrating 100% Sensitivity in Breast Cancer Detection
去年
Atossa Therapeutics' (Z)-Endoxifen Shows Promise in Phase 2 Breast Cancer Trial
第 1 页,共 1512 页
上一页
下一页